Zobrazeno 1 - 10
of 53
pro vyhledávání: '"Anja Reuter"'
Publikováno v:
The Lancet Global Health, Vol 10, Iss 10, Pp e1387- (2022)
Externí odkaz:
https://doaj.org/article/6b921ee7bfe043058229807167c0100d
Autor:
Anja Reuter, Jennifer Furin
Publikováno v:
Pathogens, Vol 12, Iss 5, p 728 (2023)
An estimated 19 million people are infected with rifampicin-resistant/multidrug-resistant strains of tuberculosis worldwide. There is little done to prevent these individuals from becoming sick with RR/MDR-TB, a disease that is associated with high r
Externí odkaz:
https://doaj.org/article/250f2fcd31a44a7197cc9c068900474f
Autor:
Helen Cox, ProfPhD, Zubeida Salaam-Dreyer, PhD, Galo A Goig, PhD, Mark P Nicol, ProfPhD, Fabrizio Menardo, PhD, Anzaan Dippenaar, PhD, Erika Mohr-Holland, MPH, Johnny Daniels, BA, Patrick G T Cudahy, PhD, Sonia Borrell, PhD, Miriam Reinhard, MD, Anna Doetsch, MSc, Christian Beisel, PhD, Anja Reuter, MD, Jennifer Furin, MD, Sebastien Gagneux, ProfPhD, Robin M Warren, ProfPhD
Publikováno v:
The Lancet Microbe, Vol 2, Iss 11, Pp e584-e593 (2021)
Summary: Background: South Africa has a high burden of rifampicin-resistant tuberculosis (including multidrug-resistant [MDR] tuberculosis), with increasing rifampicin-monoresistant (RMR) tuberculosis over time. Resistance acquisition during first-li
Externí odkaz:
https://doaj.org/article/eabc95b2fba449618f5b7dcb2a25c8ac
Autor:
Erika Mohr-Holland, Anja Reuter, Jennifer Furin, Anthony Garcia-Prats, Virginia De Azevedo, Vanessa Mudaly, Yulene Kock, Laura Trivino-Duran, Petros Isaakidis, Jennifer Hughes
Publikováno v:
EClinicalMedicine, Vol 20, Iss , Pp - (2020)
Background: Limited data exist on the use of bedaquiline and delamanid in adolescents with rifampicin-resistant tuberculosis (RR-TB). We describe RR-TB treatment of adolescents (10–19 years) with injectable-free regimens containing these drugs in K
Externí odkaz:
https://doaj.org/article/469c98a39c1048e9b291e9296219bf98
Autor:
Anja Reuter, Buci Beko, Boniwe Memani, Jennifer Furin, Johnny Daniels, Erickmar Rodriguez, Hermann Reuter, Lize Weich, Petros Isaakidis, Erin von der Heyden, Yulene Kock, Erika Mohr-Holland
Publikováno v:
Tropical Medicine and Infectious Disease, Vol 7, Iss 2, p 21 (2022)
Substance use (SU) is associated with poor rifampicin-resistant tuberculosis (RR-TB) treatment outcomes. In 2017, a SBIRT (SU screening-brief intervention-referral to treatment) was integrated into routine RR-TB care in Khayelitsha, South Africa. Thi
Externí odkaz:
https://doaj.org/article/07052e021643445cbfb2fc1e87096963
Autor:
Stella Zawedde-Muyanja, Anja Reuter, Marco A. Tovar, Hamidah Hussain, Aime Loando Mboyo, Anne K. Detjen, Courtney M. Yuen
Publikováno v:
Pathogens, Vol 10, Iss 12, p 1568 (2021)
In this review, we discuss considerations and successful models for providing decentralized diagnosis, treatment, and prevention services for children and adolescents. Key approaches to building decentralized capacity for childhood TB diagnosis in pr
Externí odkaz:
https://doaj.org/article/a11f7e299bb04d489d92bc364d46216d
Autor:
Harry Moultrie, Ebrahim Variava, Zaheda Bhyat., Martin Enwerem, Simon Schaaf, Xavier Padanilam, Norbert Ndjeka, Nana Okozi, Minty van der Meulen, Lavania Joseph, Yulene Kock, Shaheed V. Omar, Nazir Ahmed Ismail, Hannetjie Ferreira, Francesca Conradie, Vancy Letsaolo, Anja Reuter, Gary Maartens, Farzana Ismail, Jennifer Hughes, Julian Te Riele, Rodolf Romero, Graeme Meintjes, Dumisani Ngcamu
Publikováno v:
The Lancet Infectious Diseases. 22:496-506
Summary Background Bedaquiline improves outcomes of patients with rifampicin-resistant and multidrug-resistant (MDR) tuberculosis; however, emerging resistance threatens this success. We did a cross-sectional and longitudinal analysis evaluating the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6da4ddde1345bae8016a82b65e5a1081
https://doi.org/10.1016/s1473-3099(21)00470-9
https://doi.org/10.1016/s1473-3099(21)00470-9
Autor:
Ivy Apolisi, Helen Cox, Nolitha Tyeku, Johnny Daniels, Shaheed Mathee, Rabia Cariem, Bianca Douglas-Jones, Noluvo Ngambu, Vanessa Mudaly, Erika Mohr-Holland, Petros Isaakidis, Colin Pfaff, Jennifer Furin, Anja Reuter
Publikováno v:
Open Forum Infectious Diseases. 10
BackgroundChildren and adolescents with household exposure to multidrug- or rifampicin-resistant tuberculosis (MDR/RR-TB) are at high risk of developing TB disease. Tuberculosis preventive therapy (TPT) is recommended, but programmatic experience is
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9af57d255cd001b82a9e4bac40bce8dd
https://doi.org/10.1093/ofid/ofad087
https://doi.org/10.1093/ofid/ofad087
Autor:
Anja Reuter, Jennifer Furin
Publikováno v:
Lancet (London, England). 400(10362)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a0eff41801b5899b3c4497d42874da40
https://pubmed.ncbi.nlm.nih.gov/36522197
https://pubmed.ncbi.nlm.nih.gov/36522197
Autor:
Helen Cox, Galo A. Goig, Zubeida Salaam-Dreyer, Anzaan Dippenaar, Anja Reuter, Erika Mohr-Holland, Johnny Daniels, Patrick G. T. Cudahy, Mark P. Nicol, Sonia Borrell, Miriam Reinhard, Anna Doetsch, Christian Beisel, Sebastien Gagneux, Robin M. Warren, Jennifer Furin
Publikováno v:
Journal of Clinical Microbiology, 60 (3)
Journal of clinical microbiology
Journal of clinical microbiology
Treatment of multidrug-resistant or rifampicin-resistant tuberculosis (MDR/RR-TB), although improved in recent years with shorter, more tolerable regimens, remains largely standardized and based on limited drug susceptibility testing (DST). More indi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::eac477d52e0080735bee8de4239da64d
https://hdl.handle.net/20.500.11850/543517
https://hdl.handle.net/20.500.11850/543517
